BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12355884)

  • 41. A classification of CSF shunt malfunction.
    Gilkes CE; Steers AJ; Minns RA
    Eur J Pediatr Surg; 1999 Dec; 9 Suppl 1():19-22. PubMed ID: 10661785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ventriculoperitoneal shunt of continuous flow vs valvular shunt for treatment of hydrocephalus in adults.
    Sotelo J; Arriada N; López MA
    Surg Neurol; 2005 Mar; 63(3):197-203; discussion 203. PubMed ID: 15734497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical parameters in 74 consecutive patients shunt operated for normal pressure hydrocephalus.
    Larsson A; Wikkelsö C; Bilting M; Stephensen H
    Acta Neurol Scand; 1991 Dec; 84(6):475-82. PubMed ID: 1792852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting the outcome of shunt surgery in normal pressure hydrocephalus.
    Kilic K
    Acta Neurochir (Wien); 2009 Jan; 151(1):105; author reply 107. PubMed ID: 19129960
    [No Abstract]   [Full Text] [Related]  

  • 45. Performance of the fixed pressure valve with antisiphon device SPHERA® in the treatment of normal pressure hydrocephalus and prevention of overdrainage.
    Pereira RM; Suguimoto MT; Oliveira MF; Tornai JB; Amaral RA; Teixeira MJ; Pinto FC
    Arq Neuropsiquiatr; 2016 Jan; 74(1):55-61. PubMed ID: 26602193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcome in patients with suspected normal pressure hydrocephalus.
    Kahlon B; Sjunnesson J; Rehncrona S
    Neurosurgery; 2007 Feb; 60(2):327-32; discussion 332. PubMed ID: 17290183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unilateral hearing loss following shunt placement for normal pressure hydrocephalus with a unilateral patent cochlear aqueduct.
    Lee SH; Park SH; Park J; Hwang SK
    Clin Neurol Neurosurg; 2007 Nov; 109(9):799-802. PubMed ID: 17643785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reflex sympathetic dystrophy after modified radical mastectomy: a case report.
    Saddison DK; Vanek VW
    Surgery; 1993 Jul; 114(1):116-20. PubMed ID: 8356515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reflex sympathetic dystrophy following transbrachial cardiac catheterization.
    Inoue T; Yaguchi I; Mizoguchi K; Iwasaki Y; Takayanagi K; Morooka S; Asano S
    J Invasive Cardiol; 2000 Sep; 12(9):481-3. PubMed ID: 10973376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ventriculopleural shunt: thoracoscopic placement of the distal catheter.
    Kurschel S; Eder HG; Schleef J
    Surg Endosc; 2003 Nov; 17(11):1850. PubMed ID: 14959734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subarachnoid hemorrhage manifested by intestinal ileus in a patient with a ventriculoperitoneal shunt. Case report.
    Forrest PD; Lesser RM; Corkill G
    J Neurosurg; 1974 Oct; 41(4):499-501. PubMed ID: 4415971
    [No Abstract]   [Full Text] [Related]  

  • 52. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
    BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of visual loss caused by shunt failure: a potential role for optic nerve sheath fenestration. Report of three cases.
    Ramsey CN; Proctor BL; Baker RS; Pittman T
    J Neurosurg; 2006 Feb; 104(2 Suppl):149-51. PubMed ID: 16506504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrospinal fluid analysis: a predictor of chronic hydrocephalus following spontaneous subarachnoid hemorrhage.
    Bunyaratavej K; O'charoen S
    J Med Assoc Thai; 2004 Aug; 87(8):898-901. PubMed ID: 15471293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antisiphon device: A review of existing mechanisms and clinical applications to prevent overdrainage in shunted hydrocephalic patients.
    Huang AP; Kuo LT; Lai DM; Yang SH; Kuo MF
    Biomed J; 2022 Feb; 45(1):95-108. PubMed ID: 34411787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lumbar subcutaneous shunt: a novel technique for therapeutic decision making in normal pressure hydrocephalus (NPH) and benign intracranial hypertension (BIH).
    Ushewokunze S; Haja Mydin HN; Prasad R; Mendelow AD
    Br J Neurosurg; 2008 Oct; 22(5):678-81. PubMed ID: 19016120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
    Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
    J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of cerebrospinal fluid shunts: part I: Obstruction and mechanical failure.
    Browd SR; Ragel BT; Gottfried ON; Kestle JR
    Pediatr Neurol; 2006 Feb; 34(2):83-92. PubMed ID: 16458818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of shunt-induced intracerebral hemorrhage by postoperative skull films: a report of two cases.
    Derdeyn CP; Delashaw JB; Broaddus WC; Jane JA
    Neurosurgery; 1988 Apr; 22(4):755-7. PubMed ID: 3374789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preoperative spinal hydrodynamics versus clinical change 1 year after shunt treatment in idiopathic normal pressure hydrocephalus patients.
    Eide PK; Sorteberg W
    Br J Neurosurg; 2005 Dec; 19(6):475-83. PubMed ID: 16574559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.